Other OTC - Delayed Quote • USD
Q BioMed Inc. (QBIO)
As of April 18 at 2:32 PM EDT. Market Open.
Insider Purchases Last 6 Months
| Shares | Transactions | |
|---|---|---|
| Purchases | 0 | 0 |
| Sales | -- | 0 |
| Net Shares Purchased (Sold) | 0 | 0 |
| Total Insider Shares Held | 4.33M | -- |
| % Net Shares Purchased (Sold) | -- | -- |
Net Institutional Purchases Prior Quarter to Latest Quarter
| Shares | |
|---|---|
| Net Shares Purchased (Sold) | -- |
| % Change in Institutional Shares Held | -- |
Insider Transactions Reported - Last Two Years
| Insider | Transaction | Type | Value | Date |
|---|---|---|---|---|
| ROSENSTADT WILLIAM S Officer, Director and Beneficial Owner | Stock Award(Grant) at price 0.10 per share. | Direct | 25,000 | May 26, 2022 |
| CORIN DENIS Chief Executive Officer | Stock Award(Grant) at price 0.10 per share. | Direct | 20,000 | May 26, 2022 |
| ROSENSTADT WILLIAM S Officer, Director and Beneficial Owner | -- | Direct | -- | Feb 1, 2021 |
| ROSENSTADT WILLIAM S Officer, Director and Beneficial Owner | -- | Direct | -- | Oct 16, 2019 |
| PANICUCCI RICK Director | -- | Direct | -- | Oct 9, 2019 |
| CORIN DENIS Chief Executive Officer | Sale at price 2.11 per share. | Direct | 13,530 | Jul 12, 2018 |
| CORIN DENIS Chief Executive Officer | Sale at price 2.85 - 3.37 per share. | Direct | 43,512 | Jul 10, 2018 |
| CORIN DENIS Chief Executive Officer | Sale at price 3.54 - 3.58 per share. | Direct | 48,032 | Jul 6, 2018 |
| CORIN DENIS Chief Executive Officer | Sale at price 3.42 - 3.46 per share. | Direct | 14,446 | Jul 3, 2018 |
| CORIN DENIS Chief Executive Officer | Sale at price 3.39 - 3.40 per share. | Direct | 25,099 | Jun 29, 2018 |
| CORIN DENIS Chief Executive Officer | Sale at price 3.42 - 3.44 per share. | Direct | 34,652 | Jun 27, 2018 |
| CORIN DENIS Chief Executive Officer | Sale at price 3.45 - 3.47 per share. | Direct | 31,153 | Jun 21, 2018 |
| LINDSAY ALAN P Beneficial Owner of more than 10% of a Class of Security | Sale at price 5.25 - 6.54 per share. | Direct | 72,712 | Apr 11, 2017 |
| ROSENSTADT WILLIAM S General Counsel | Sale at price 5.29 - 7.60 per share. | Direct | 61,276 | Mar 30, 2017 |
| ROSENSTADT WILLIAM S General Counsel | Sale at price 2.90 - 5.09 per share. | Direct | 225,445 | Mar 28, 2017 |
| ROSENSTADT WILLIAM S General Counsel | Stock Gift at price 0.00 per share. | Direct | 0 | Jul 18, 2016 |
Related Tickers
AURX Nuo Therapeutics, Inc.
0.8000
0.00%
MRES Institute of Biomedical Research Corp.
0.0124
0.00%
NAVB Navidea Biopharmaceuticals, Inc.
0.0376
0.00%
ACIU AC Immune SA
2.4295
+6.09%
PMN ProMIS Neurosciences, Inc.
1.9500
-3.94%
MORF Morphic Holding, Inc.
27.52
-1.64%
CNTX Context Therapeutics Inc.
1.3800
-1.43%
CMND Clearmind Medicine Inc.
1.1962
+0.52%
APS.TO Aptose Biosciences Inc.
1.6900
+4.32%
LYRA Lyra Therapeutics, Inc.
5.07
-1.93%